Literature DB >> 24057654

Supramolecular Study on the Interaction Between Ofloxacin and Methyl β-Cyclodextrin by Fluorescence Spectroscopy and its Analytical Application.

Abdalla A Elbashir1, Nuha Fathi Ali Dsugi2, Hassan Y Aboul-Enein3.   

Abstract

The supramolecular interaction of ofloxacin (Oflo) and methyl β-cyclodextrin (Mβ-CD) has been examined by UV-vis, IR and fluorescence spectroscopy. The formation of inclusion complex has been confirmed based on the changes of the spectral properties. The results showed that Mβ-CD reacted with Oflo to form an inclusion complex. The Oflo and Mβ-CD complex formed a host-guest complex in 1:1 stoichiometry and inclusion constant (K = 7.8 × 10(-3) L mol(-1)) was ascertained by the typical double reciprocal plots. Furthermore, the thermodynamic parameters (∆H°, ∆S° and ∆G°) associated with the inclusion process were also determined. In addition, solid inclusion complex was synthesized. Based on the significant enhancement of the fluorescence intensity of Oflo produced through complex formation, a simple, accurate, rapid and highly sensitive spectrofluorometric method for the determination of Oflo in pharmaceutical formulation was developed. The measurement of relative fluorescence intensity was carried out at 497 nm with excitation at 296 nm. The factors affecting the inclusion complex formation were studied and optimized. Under the optimum reaction conditions, linear relationships with good correlation coefficients (0.9995) were in the concentration range of 50-350 ng/mL for spectrofluorimetry. The limit of detection (LOD) was 11.5 ng/mL. The proposed method was successfully applied to the analysis of Oflo in pharmaceutical preparation.

Entities:  

Keywords:  Inclusion complex; Methylβ-CD; Ofloxacin; Spectrofluorimetry; Supramolecular study

Mesh:

Substances:

Year:  2013        PMID: 24057654     DOI: 10.1007/s10895-013-1300-0

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  19 in total

1.  Determination of the antibacterial ofloxacin in human urine and serum samples by solid-phase spectrofluorimetry.

Authors:  Oscar Ballesteros; José Luis Vílchez; Alberto Navalón
Journal:  J Pharm Biomed Anal       Date:  2002-11-07       Impact factor: 3.935

2.  Differential pulse polarographic determination of ofloxacin in pharmaceuticals and biological fluids.

Authors:  M Rizk; F Belal; F A Aly; N M El-Enany
Journal:  Talanta       Date:  1998-05       Impact factor: 6.057

3.  Computational modeling of capillary electrophoretic behavior of primary amines using dual system of 18-crown-6 and β-cyclodextrin.

Authors:  Abdalla A Elbashir; FakhrEldin O Suliman
Journal:  J Chromatogr A       Date:  2011-06-17       Impact factor: 4.759

4.  Preparation and characterization of inclusion complexes of pefloxacin mesylate with three kinds of cyclodextrins.

Authors:  Jian-Bin Chao; Hong-Bo Tong; Dian-Sheng Liu; Shu-Ping Huang
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2005-08-10       Impact factor: 4.098

5.  The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.

Authors:  Leroy A Shervington; Michael Abba; Bushra Hussain; James Donnelly
Journal:  J Pharm Biomed Anal       Date:  2005-09-15       Impact factor: 3.935

6.  Enantioseparation of ofloxacin in urine by capillary electrokinetic chromatography using charged cyclodextrins as chiral selectors and assessment of enantioconversion.

Authors:  T de Boer; R Mol; R A de Zeeuw; G J de Jong; K Ensing
Journal:  Electrophoresis       Date:  2001-04       Impact factor: 3.535

7.  Development of cyclodextrin microspheres for pulmonary drug delivery.

Authors:  Malika Skiba; Frédéric Bounoure; Cecile Barbot; Philippe Arnaud; Mohamed Skiba
Journal:  J Pharm Pharm Sci       Date:  2005-08-24       Impact factor: 2.327

8.  Determination of ofloxacin in human serum by high-performance liquid chromatography with column switching.

Authors:  T Ohkubo; M Kudo; K Sugawara
Journal:  J Chromatogr       Date:  1992-01-17

9.  Preparation and study on the solid inclusion complex of sparfloxacin with HP-beta-cyclodextrin.

Authors:  Jianbin Chao; Jiangsong Li; Dongping Meng; Shuping Huang
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2003-03-01       Impact factor: 4.098

10.  Preparation and study on the solid inclusion complex of sparfloxacin with beta-cyclodextrin.

Authors:  Jian-Bin Chao; Hong-Bo Tong; Shu-Ping Huang; Dian-Sheng Liu
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2004-01       Impact factor: 4.098

View more
  1 in total

Review 1.  Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.

Authors:  Dariusz Boczar; Katarzyna Michalska
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.